Spots Global Cancer Trial Database for papillomavirus
Every month we try and update this database with for papillomavirus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | NCT03185013 | Cervical Dyspla... Cervical High G... HSIL | VGX-3100 Placebo Electroporation... | 18 Years - | Inovio Pharmaceuticals | |
| Natural History of HPV Infection in Men: The HIM Study | NCT00786760 | Human Papilloma... | Cohort: 3000 me... Pilot study: 15... | 18 Years - 70 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer | NCT02137694 | Research Human ... | vaginal auto-ta... | 25 Years - 65 Years | University Hospital, Brest | |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand | NCT00849381 | Infections, Pap... | GSK580299, GSK ... | 26 Years - | GlaxoSmithKline | |
| Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal | NCT03584308 | Papilloma Viral... Papillomavirus ... Esophageal Vira... Esophageal Verr... | Viusid® Glizigen® Viusid Placebo Glizigen Placeb... | 18 Years - 65 Years | Catalysis SL | |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand | NCT00849381 | Infections, Pap... | GSK580299, GSK ... | 26 Years - | GlaxoSmithKline | |
| A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer | NCT02172911 | Cervical Cancer | INO-3112 CELLECTRA™-5P | 18 Years - | Inovio Pharmaceuticals | |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand | NCT00849381 | Infections, Pap... | GSK580299, GSK ... | 26 Years - | GlaxoSmithKline | |
| Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females | NCT00586339 | Infections, Pap... | Cervarix Placebo Control | 18 Years - 25 Years | GlaxoSmithKline | |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US | NCT00799825 | Infections, Pap... | GSK Biological'... | 18 Years - | GlaxoSmithKline | |
| REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | NCT03185013 | Cervical Dyspla... Cervical High G... HSIL | VGX-3100 Placebo Electroporation... | 18 Years - | Inovio Pharmaceuticals | |
| Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age | NCT00552279 | Infections, Pap... | Cervarix TM Cervarix TM | 15 Years - 25 Years | GlaxoSmithKline | |
| Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer | NCT02137694 | Research Human ... | vaginal auto-ta... | 25 Years - 65 Years | University Hospital, Brest | |
| Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma | NCT02163057 | Head and Neck S... | INO-3112 CELLECTRA™-5P | 18 Years - | Inovio Pharmaceuticals | |
| A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer | NCT02172911 | Cervical Cancer | INO-3112 CELLECTRA™-5P | 18 Years - | Inovio Pharmaceuticals | |
| Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma | NCT02163057 | Head and Neck S... | INO-3112 CELLECTRA™-5P | 18 Years - | Inovio Pharmaceuticals | |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand | NCT00849381 | Infections, Pap... | GSK580299, GSK ... | 26 Years - | GlaxoSmithKline | |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US | NCT00799825 | Infections, Pap... | GSK Biological'... | 18 Years - | GlaxoSmithKline | |
| REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | NCT03721978 | Cervical Dyspla... Cervical High G... HSIL | VGX-3100 Placebo CELLECTRA™-5PSP | 18 Years - | Inovio Pharmaceuticals | |
| Molecular Markers in Cancers and Precancers (MOCA) | NCT05257707 | Cancer Precancerous Le... Healthy | Molecular biolo... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer | NCT03856684 | Cervical Cancer... Cervical Cancer | Self-sampling k... Self-sampling k... Letter offering... SMS offering a ... | 30 Years - 66 Years | University Hospital, Tours |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
